Home » Scientific Sessions » 2022 » Page 3

  • Kelly West Award Lecture outlines precision prevention for type 1 diabetes

    Kelly West Award Lecture outlines precision prevention for type 1 diabetes

    IJust as precision medicine matches treatment approaches with individuals most likely to respond, precision prevention matches prevention measures to those most likely to show benefit. Jill M. Norris, MPH, PhD, discussed the interplay between genetic and dietary factors in reducing the risk of type 1 diabetes during this year’s Kelly West Award for Outstanding Achievement…

  • Exercise during pregnancy improves outcomes for mothers and babies

    Exercise during pregnancy improves outcomes for mothers and babies

    Expectant mothers who exercise have greater levels of docosahexaenoic acid (DHA) in late pregnancy than those who do not, explained Linda May, PhD, MS, FAHA. DHA helps mothers deliver on time, is good for placentas, helps control the mother’s lipids, and is essential for the baby’s growth and development.

  • NCCC recommends new strategy for prevention and control of diabetes focused on societal factors

    NCCC recommends new strategy for prevention and control of diabetes focused on societal factors

    In a report to Congress earlier this year, the National Clinical Care Commission (NCCC) outlined more than three dozen recommendations for a national effort across multiple agencies and levels of government to address social determinants in the pathogenesis and progression of diabetes. NCCC Chair William H. Herman, MD, MPH, and other Commission members highlighted their…

  • Trials indicate incretin therapy can prevent and better manage type 2 diabetes

    Trials indicate incretin therapy can prevent and better manage type 2 diabetes

    As type 2 diabetes medications have become more effective, management goals have become more ambitious, said Rodolfo J. Galindo, MD, FACE. It is no longer enough to lower A1C. The ideal type 2 diabetes medication can control glycemia with low risk of hypoglycemia and produce beneficial effects on beta cell function, weight loss, and cardiorenal…

  • New incretins poised to improve clinical care and cardiometabolic outcomes

    New incretins poised to improve clinical care and cardiometabolic outcomes

    Carol H. Wysham, MD, says there is serious therapeutic inertia at play as patients often remain in poor glycemic control for more than seven years before intensification of treatment. Yet repeated studies show that up-titrating GLP-1 receptor agonist dosing improves glycemic outcomes as well as loss and maintenance of weight.

  • Obesity, diabetes can play a role in dementia

    Obesity, diabetes can play a role in dementia

    Obesity can lead to insulin resistance, which sets the stage for the development of beta amyloid plaques and tau tangles in the brain, both hallmarks of Alzheimer’s disease. Some early trials of inhaled insulin in people with type 2 diabetes show improved memory, Auriel A. Willette, PhD, MS, and Vera Novak, MD, PhD, explained.

  • Panel: Helping young adults manage diabetes requires better education

    Panel: Helping young adults manage diabetes requires better education

    An expert panel including Paul McGuigan, RN, CDCES, stressed that creating a continuum of care and support starting in high school, including promoting health insurance literacy, is key to setting up young people with type 2 diabetes to successfully manage their disease as they transition to adulthood.

  • Research begins to explain why time of day affects efficacy of interventions such as exercise in type 2 diabetes

    Research begins to explain why time of day affects efficacy of interventions such as exercise in type 2 diabetes

    Afternoon training improves glucose sensitivity, increases fat loss, and increases work performance while reducing nocturnal blood glucose levels, said Juleen R. Zierath, PhD, one of the panelists discussing the molecular mechanisms known to affect the circadian rhythms of liver function.

  • Presenter Profiles: Automated Insulin Delivery, Pumps, and Continuous Glucose Monitors in School— What You Need to Know

    Presenter Profiles: Automated Insulin Delivery, Pumps, and Continuous Glucose Monitors in School— What You Need to Know

    Anastasia Albanese-O’Neill, PhD, APRN, CDCES, discusses the research behind this presentation at the 82nd Scientific Sessions. An on-demand recording can be viewed on the meeting’s virtual platform through September 5, 2022.

  • Presenter Profiles: Disparities in Diabetes Risk Factors, Disease Prevention, and Complications among LGBTQ Populations

    Presenter Profiles: Disparities in Diabetes Risk Factors, Disease Prevention, and Complications among LGBTQ Populations

    Carl G. Streed Jr, MD, MPH, discusses the research behind this presentation at the 82nd Scientific Sessions. An on-demand recording can be viewed on the meeting’s virtual platform through September 5, 2022.

0